Related Experiment Video
Updated: Jun 26, 2026

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
Published on: March 14, 2016
The immunostimulatory effect of IL-1beta in vivo is blocked by antisense peptides complementary to the loop sequence
Diana Boraschi1, Aldo Tagliabue, Andrew D Miller
1Laboratory of Cytokines, Unit of Immunobiology, Institute of Biomedical Technologies (ITB), National Research Council (CNR), Area della Ricerca di S. Cataldo, Via G. Moruzzi 1, I-56124 Pisa, Italy.
Antisense (AS) peptides complementary to the beta-bulge surface loop VQGEESNDK (Boraschi loop) of the cytokine interleukin-1beta (IL-1beta) have been shown to bind IL-1beta at the Boraschi loop position, and to inhibit some of the IL-1beta-mediated biological effects in vitro. Here we show that primary AS peptide FVITFFSLY inhibits IL-1beta-mediated immunostimulation in vivo in a dose-dependent fashion, while inactive on IL-1beta-induced inflammation, an effect that takes place independently of the Boraschi loop. To the best of our knowledge, this is the first time that an AS peptide has been used successfully in vivo.
Antisense (AS) peptides complementary to the beta-bulge surface loop VQGEESNDK (Boraschi loop) of the cytokine interleukin-1beta (IL-1beta) have been shown to bind IL-1beta at the Boraschi loop position, and to inhibit some of the IL-1beta-mediated biological effects in vitro. Here we show that primary AS peptide FVITFFSLY inhibits IL-1beta-mediated immunostimulation in vivo in a dose-dependent fashion, while inactive on IL-1beta-induced inflammation, an effect that takes place independently of the Boraschi loop. To the best of our knowledge, this is the first time that an AS peptide has been used successfully in vivo.
More Related Videos
Related Concept Videos
The JAK-STAT Signaling Pathway
Inhibitors of Viral Protein Synthesis
TGF - β Signaling Pathway

